Who we are
In 2016 Prof. A. Bechthold from the University of Freiburg and Prof H. Pfundner from Roche created the idea of a new specialty line “Drug Development & Regulatory Affairs” within the existing Master’s degree program in pharmaceutical sciences. There is a need in the industry for university graduates with sound knowledge in the areas of pharmaceutical drug development and regulatory affairs. These topics are usually underrepresented in existing pharmacy degree programs.
Vision and Goals
By connecting pharmacy students with the Pharmaceutical industry and academic partners our organization facilitates a network between these parties. In a global world the pharmacy student of today wants to be involved and connected to potential employers as early as possible. He/she wants to gain experience and insights to the pharmaceutical industry.
Membership / Donations
We need your financial contribution to support our projects.
Become a member of our organization or support our work by a one-time donation
News blog
Schedule of the association in 2023
- Vorstandstreffen 31.3.2023 online
- Vorstandstreffen f2f at location at Dr. Friederike Zahm
- Get together with all lecturers on 9.5.2023 at location at Prof. Helmuth Laaf
- Get together with students of the scholarship and mentors on 14.7.2023 at location Prof. Andreas Bechthold
- Annual meeting of the association on 17.10.2023 at location at Institute of Dermatohistology, Pathology und Molekularpathology of Prof. Laaff
Master student Isabelle Roux rewarded by the German association for market access
In 2022, the German association for market access, Deutsche Fachgesellschaft für Market Access e.V., rewarded Isabelle Roux, one of our Master students for her Master thesis: Auswirkungen der bedingten Zulassung von Medikamenten auf die Erstattung in der EU.
This is an excellent example for the quality and high topicality of the Master theses within our program. Congrats to Isabelle!
The Phoenix Pharmacy Science Award 2021 at the Category Pharmaceutical Biology was currently awarded to Prof. Dr. A. Bechthold and his Research Group.
The research group is thus awarded for its outstanding work and publication “Secondary nucleotide messenger c-di-GMP exerts a global control on natural product biosynthesis in streptomycetes” in the journal “Nucleic Acid Research“, carried out by Dr. Roman Makitrynskyy, Olga Tsypik, Desirée Nuzzo of the working group in cooperation with Dr. Thomas Paululat, head of NMR facilities and research associate at the University of Siegen, and Prof. Dr. David L. Zechel, Department of Chemistry, Queen’s University, Kingston, Ontario, Canada under the direction of Prof. Dr. Andreas Bechthold.
Master’s program “Regulatory Affairs & Drug Development

At the winter semester and in further study years, there will be another opportunity to enroll in the unique Master’s program “Regulatory Affairs & Drug Development” at the Institute of Pharmaceutical Sciences of the Albert-Ludwigs-University of Freiburg. It is best to register with your study coordinator as soon as possible using this form.
Watch this video to find a short introduction into the study program.
You can find even more information about the master’s program via this recording of an information event about the master profile line from Mai of 2021. The recording also starts with the previous introduction video.
Interview with Prof. Dr. Andreas Bechthold, Executive Director of the Institute of Pharmaceutical Sciences of the Albert-Ludwigs-University of Freiburg, about the Master’s Program “Regulatory Affairs & Drug Development” (in German only)
Interview with Prof. Dr. Helmut Laaff , CEO – Institut für Dermatohistology, Pathology, Molecular Pathology, about the Master’s Program “Regulatory Affairs & Drug Development” (in German only)
Interview with Daniela Dietz, Head of Regulatory ad Dr. Regenold GmbH, about the Master’s Program “Regulatory Affairs & Drug Development” (in German only)
Video Testimonials of (former) Students of the Master’s Program “Regulatory Affairs & Drug Development”